Actively Recruiting
Safety & Efficacy of Qurs e Fishar in Mild to Moderate Hypertensive Patients in Pakistan
Led by Abdul Bari · Updated on 2025-02-28
119
Participants Needed
1
Research Sites
105 weeks
Total Duration
On this page
Sponsors
A
Abdul Bari
Lead Sponsor
H
Hamdard University
Collaborating Sponsor
AI-Summary
What this Trial Is About
The herbal medicine Qurs-e-Fishar to treat mild to moderate High blood pressure or hypertension comprises of Rauwolfia serpentina. A product of Hamdard Laboratories (Waqf) Pakistan. A Phase III Safety \& Efficacy Open-label, Single-Arm, Interventional, Multicenter, Study in mild to moderate hypertensive, adults (30 to 60 years of age) prescribed with study product for 12 weeks (84 days). Primary End Points: 1. Reduction in diastolic blood pressure less than 130 / 80 mmHg at the end of the study period (accepted by WHO) or if there was a fall of 20 / 10 mmHg or more in diastolic blood pressure as compared to baseline. 2. Type, frequency and severity of ADRs during the study period. Secondary End Points: 1\. Compliance of the prescribed study medication.
CONDITIONS
Official Title
Safety & Efficacy of Qurs e Fishar in Mild to Moderate Hypertensive Patients in Pakistan
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Ability to sign informed consent form
- Willing and able to follow the study protocol
- Diagnosed with mild to moderate hypertension
- Mild hypertension defined as 140-159/90-99 mm Hg
- Moderate hypertension defined as 160-179/100-109 mm Hg
- Age between 30 and 60 years
You will not qualify if you...
- Severe hypertension
- Congestive cardiac failure
- Left ventricular failure
- Myocardial ischemia
- Renal failure
- Cerebrovascular accidents
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Taj Medical Complex, Hamdard University Hospital
Karachi, Sindh, Pakistan
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here